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Granulopoiesis is a dynamic process leading   
to the production of 120 billion granulocytes 
daily in humans; its synthetic capacity can be 
increased at least 10-fold in response to certain 
stress conditions, such as infection. Granulo-
poiesis follows an orchestrated program of cell 
proliferation, differentiation, and apoptosis,   
resulting in the expansion of a small pool of 
stem cells that evolve from granulocytic pro-
genitors/precursors to mature granulocytes. 
Neutrophils are the most abundant type of 
granulocyte, whereas eosinophils and basophils 
are much rarer. Originating from stem cells and 
progenitors, neutrophils in the bone marrow 
are comprised of a precursor pool and a storage 
pool. Peripheral blood neutrophils, which are 
postmitotic, consist of a free circulating pool 
and a marginal pool.
Granulocyte-colony  stimulating  factor   
(G-CSF) plays a major role in regulating granu-
lopoiesis (1). G-CSF not only stimulates the 
proliferation of granulocytic precursors (2), but 
also prolongs neutrophil survival (3) and reduces 
the mean transit time from granulocytic pro-
genitors/precursors to mature granulocytes (4). 
The importance of G-CSF in granulopoiesis 
was demonstrated in G-CSF KO mice. These 
mice only have 20% of the normal circulating 
neutrophils and a correspondingly small neutro-
phil precursor pool in their bone marrow (5).
The biological action of androgens is me-
diated through the androgen receptor (AR), a 
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Neutrophils, the major phagocytes that form the first line of cell-mediated defense against 
microbial infection, are produced in the bone marrow and released into the circulation in 
response to granulocyte-colony stimulating factor (G-CSF). Here, we report that androgen 
receptor knockout (ARKO) mice are neutropenic and susceptible to acute bacterial infec-
tion, whereas castration only results in moderate neutrophil reduction in mice and humans. 
Androgen supplement can restore neutrophil counts via stabilizing AR in castrated mice, 
but not in ARKO and testicular feminization mutant (Tfm) mice. Our results show that 
deletion of the AR gene does not influence myeloid lineage commitment, but significantly 
reduces the proliferative activity of neutrophil precursors and retards neutrophil matura-
tion. CXCR2-dependent migration is also decreased in ARKO neutrophils as compared with 
wild-type controls. G-CSF is unable to delay apoptosis in ARKO neutrophils, and ARKO mice 
show a poor granulopoietic response to exogenous G-CSF injection. In addition, AR can 
restore G-CSF–dependent granulocytic differentiation upon transduction into ARKO pro-
genitors. We further found that AR augments G-CSF signaling by activating extracellular 
signal-regulated kinase 1/2 and also by sustaining Stat3 activity via diminishing the inhibi-
tory binding of PIAS3 to Stat3. Collectively, our findings demonstrate an essential role for 
AR in granulopoiesis and host defense against microbial infection.
© 2009 Chuang et al.  This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.jem.org/misc/terms.shtml). After six 
months it is available under a Creative Commons License (Attribution–Noncom-
mercial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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Figure 1.  AR-targeted disruption and analysis of peripheral neutrophils in ARKO mice. (A) Schematic representation of murine AR protein do-
mains and corresponding exons in AR mRNA. The AR mRNA is composed of seven exons; exon 2 is removed in ARKO mice. DBD, DNA-binding domain. 
LBD, ligand-binding domain. (B) The purity of isolated bone marrow neutrophils from WT and ARKO mice is >90%. (C) Using the primers 5-AAT-
GGGACCTTGGATGGAGAAC-3 and 5-TCCCTGCTTCATAACATTTCCG-3, an AR transcript of 305 bp will be obtained from WT AR, but only 153 bp when 
floxed exon 2 is deleted. Full-length AR mRNA is not expressed in neutrophils isolated from bone marrow of AR-deficient mice. (D) Intracellular AR pro-
tein is not detected in neutrophils isolated from bone marrow of AR-deficient mice. Nonspecific IgG was used as primary antibody for the control.  
(E) FACS analysis of peripheral blood from 8-wk-old WT and ARKO mice. FSC and SSC of peripheral leukocytes show significant decreases of high-SSC 
granulocytic population in ARKO mice (n = 4) compared with WT littermates (n = 4). (F) FACS analyses with neutrophil-specific antibodies (clone 7/4) and 
anti-CD11b antibodies. Neutrophils are drastically reduced in ARKO mice (n = 4) compared with WT littermates (n = 4). (G) Representative photomicro-
graphs of Wright-Giemsa–stained cells on cytospins from blood after erythrocyte lysis. Neutrophils (arrow heads) are rarely found on leukocyte cytospins 
from ARKO mice compared with WT controls. Bar, 10 µm. (H) Manual differential counting of neutrophils was performed on blood smears from 9-wk-old 
sex-matched (WT), ARKO (KO), and Tfm male mice. Results are representative of four separate experiments (n = 4 per group). Data represent the mean ± SD. 
**, P < 0.01 compared with WT mice. ***, P < 0.001 compared with WT mice.
 
ligand-inducible nuclear receptor that regulates the expression 
of target genes at the transcriptional level via binding to an 
androgen-response element. Protein kinase A activators, such 
as cAMP, could activate AR transactivation activity in an 
androgen-independent manner (6). In addition, AR could be 
activated in a ligand-independent manner by epidermal growth 
factor, Her2/Neu, insulin-like growth factor 1, keratinocyte 
growth factor, and vasoactive intestinal peptide (7–9). Another 
study also suggested that activated G protein–coupled receptors 
could induce ligand-independent AR activity (10). On the other 
hand, it has been suggested that a nongenomic effect of AR may 
occur through the interaction with c-Src to induce the MAPK 
signal cascade (11). However, transcription-independent func-
tions of AR remain largely unclear.
The AR gene is located on the X chromosome and plays 
an important role in male sexual differentiation and pubertal 
sexual maturation, the maintenance of spermatogenesis, and 
male gonadotropin regulation. Phenotype analysis shows that 
AR knockout (ARKO) male mice exhibited a femalelike ex-
ternal appearance, including a vagina with a blind end, without 
penis and scrotum (12). Male reproductive organs, including 
seminal vesicles, vas deferens, epididymis, and prostate, were 
lacking in ARKO male mice. Their testes are significantly 
smaller and serum testosterone concentrations are lower in 
ARKO male mice compared with WT mice. Also, spermato-
genesis is arrested at pachytene spermatocytes in ARKO male 
mice. In female ARKO mice, retarded development of mam-
mary glands with reduced ductal branching is shown in the 
prepubertal stages (13). The ovarian dysfunction and the lower 
mean number of pups per litter were observed in adult ARKO 
female mice (14, 15). In addition to reproductive defects, the 
number/size of adipocytes and the body weight were also 
found to be decreased in ARKO mice (12).
It has been reported that AR broadly expresses in neutro-
phil-lineage cells from the myeloblast stage to the mature neu-
trophil stage with no difference in the pattern of AR expression 
between male and female (16). Androgen was found to stimulate 
proliferation of committed erythrocytic and granulocytic precur-
sors in vitro (17–20), and accelerate recovery of leukocytes after 
radiation or chemotherapy (21–25). Clinical observations with 
androgens in the treatment of aplastic anemia (26, 27), Fanconi’s 
anemia  (28,  29),  and  during  therapy  with  myelosuppressive 
agents (30, 31) suggest that androgen might increase neutrophil 
production. A clinical study with polycystic ovary syndrome 
patients who have high serum androgen levels showed higher 
neutrophil counts (32), also suggesting that androgen/AR might 
be associated with granulopoiesis. However, it is still unclear how 
androgen and AR regulate neutrophil homeostasis.
RESULTS
Targeted disruption of the AR gene in ARKO mice
Because male infertility is observed in testicular feminization mu-
tant (Tfm) mice, which carry an unstable truncated AR mutant 
(33), it is impossible to generate female homologous AR dele-
tion mice by conventional gene disruption methods. To solve 
this difficulty, we used the Cre–loxP technique to generate a 
mouse model with the targeted disruption of AR (ARKO) (12). 
We successfully generated ARKO mice of both genders and 
WT littermates, and further used these mice to investigate if loss 
of AR influences neutrophil production. In ARKO mice, the 
deletion of exon 2 in AR (Fig. 1 A) results in a splice between 
exon 1 and exon 3, creating two sequential nonsense mutations 
at new amino acid positions 533 and 534, leading to premature 
termination of the AR protein. RT-PCR analyses of total RNA 
extracted from isolated bone marrow neutrophils (Fig. 1 B) 
showed that the mRNA from ARKO neutrophils lacked the 
305-bp fragment from exon 2 of AR (Fig. 1 C), evidence that 
the intact AR is not expressed in ARKO neutrophils and pre-
cursors. Intracellular analysis of endogenous AR protein by flow 
cytometry further confirmed that AR protein expression occurs 
in WT, but not ARKO, bone marrow neutrophils (Fig. 1 D).
ARKO mice have low numbers of neutrophils in circulation
We then examined circulating neutrophils in ARKO and 
WT mice by FACS analyses. On the basis of forward scatter 
(FSC) and side scatter (SSC), FACS analyses of peripheral 
blood leukocytes showed that a high-SSC population (i.e., a 
granulocyte  population)  was  barely  detectable  in  ARKO 
mice (Fig. 1 E). Using FACS analysis with neutrophil-spe-
cific monoclonal antibodies (clone 7/4) and anti-CD11b anti-
bodies, we found that only 3% of leukocytes were neutrophils 
in ARKO mice, in contrast to 26% neutrophils in WT mice 
(Fig. 1 F). Neutrophils were rarely found in cytospin smears 
of blood leukocytes from ARKO mice (Fig. 1 G). As shown 1184 NEUTROPENIA IN AR-DEFICIENT MICE | Chuang et al.
sults demonstrated that loss of AR results in significant reduc-
tion of neutrophils in bone marrow.
To learn if both androgen and AR are required for neutro-
phil production, we examined the effects of castration and an-
drogen supplementation on neutrophil counts in WT, ARKO, 
and Tfm mice. We found that castration of normal mice only 
results  in  a  relatively  moderate  reduction  of  neutrophils  as 
compared with neutropenia in ARKO and Tfm mice (Fig. 2, 
C–E), and supplement of exogenous dihydrotestosterone 
(DHT) restores neutrophils in castrated mice, but not in ARKO 
and Tfm mice (Fig. 2, C–E). These results suggest that AR, but 
not androgen, is required for neutrophil homeostasis.
Androgen ablation reduces neutrophil counts, but does not 
result in neutropenia in humans
We also compiled blood cell counts from 33 advanced prostate 
cancer patients before and after the surgical castration therapy. 
Those patients had no prior history of chemotherapy and radia-
tion therapy, and had no sign of infection (WBC counts were 
<10,000 per l). The results showed that their neutrophil dif-
ferential counts only moderately decreased after surgical castra-
tion therapy (Fig. 2 F). The decrease of neutrophil counts in 
those patients with surgical castration was not as significant as 
that observed in ARKO mice, further supporting that androgen 
is less important than AR in neutrophil homeostasis.
by examination of blood smears with Wright-Giemsa staining, 
male and female ARKO mice have normal white blood cell 
counts, but very low percentages of neutrophils in peripheral 
blood (Fig. 1 H). Examining blood smears from Tfm mice   
(Fig. 1 H), we confirmed that loss of AR results in a significantly 
reduced neutrophil abundance in peripheral leukocytes. Auto-
mated blood analysis revealed that the numbers of total white 
blood cells, red blood cells, and platelets remained comparable in 
ARKO mice (Table I A). The mean differential ratio of periph-
eral lymphocytes in ARKO mice was increased from 75 to 94% 
without obvious alterations in monocyte and eosinophil num-
bers (Table I B). However, there was a significant reduction of 
neutrophils in blood compared with WT mice (Table I B). 
These results suggest that the AR might play a critical role in 
sustaining a normal number of circulating neutrophils in vivo.
Neutrophils are reduced in bone marrow of ARKO mice
We then sought to determine if the neutropenia in ARKO 
mice was caused by a defect in granulopoiesis in the bone 
marrow. We found that the high SSC granulocyte popula-
tion  in  bone  marrow  was  markedly  decreased  in  ARKO 
mice (Fig. 2 A). Further analysis of the granulocyte popula-
tion with clone 7/4 and CD11b antibodies demonstrated a 
50% decrease of neutrophils in bone marrow of ARKO mice 
compared with those in WT littermates (Fig. 2 B). These re-
Table I.  Blood and bone marrow analysis
Blood/bone marrow WT ARKO Statistics
A. Blood parameters WT (n = 24) ARKO (n = 18) P-value
  WBC (×103/l) 1.83 ± 0.77 1.93 ± 0.78 0.690
  RBC (×106/l) 9.18 ± 0.97 9.31 ± 0.6 0.603
  Platelets (×103/l) 643 ± 192 573.8 ± 156 0.203
  Hemoglobin (g/dl) 13.69 ± 1.04 13.43 ± 0.86 0.391
  Hematocrit (%) 49.88 ± 4.66 47.06 ± 2.88 0.021
  MCV (fl) 54.5 ± 2.73 50.61 ± 3.15 <0.001
  MCH (pg) 15.17 ± 1.05 14.39 ± 0.7 0.006
  MCHC (g/dl) 27.54 ± 1.64 28.61 ± 1.58 0.039
  Lymphocytes (per l) 1359 ± 565 1815 ± 717 0.033
  Neutrophils (per l) 420 ± 247 76 ± 59 < 0.001
B. Differential WBC WT (n=24) ARKO (n = 18) P-value
  Lymphocytes (%) 74.6 ± 7.7 94.7 ± 3.2 <0.001
  Neutrophils (%) 22.6 ± 7.2 3.7 ± 2.2 <0.001
  Eosinophils (%) 0.7 ± 0.6 0.6 ± 0.5 0.776
  Monocytes (%) 2 ± 1.7 1.2 ± 0.8 0.730
C. Bone marrow analysis  WT (n=6) ARKO (n = 6) P-value
  Myeloblasts (%) 0.6 ± 0.3 0.5 ± 0.3 0.381
  Promyelocytes (%) 2.3 ± 0.6 2.2 ± 0.4 0.583
  Myelocytes and metamyelocytes (%) 15 ± 1.6 10.3 ± 1.4 <0.001
  Neutrophils (include Band form) (%) 32 ± 2.5 12 ± 1.8 <0.001
  Bone Marrow Nucleated Cells (×106) 33.3 ± 1.24 34.1 ± 0.8 0.244
All mice for blood and bone marrow analysis range from 8 to 12 wks old. Blood parameters from blood samples obtained from heart punctures were measured using an Abbot 
CELL-DYN 4000 system. 100-count leukocyte differentials were examined on blood smears from 18–24 mice in each genotype. Bone marrow analysis was based on 1,000-
count manual leukocyte differentials performed on bone marrow–nucleated cells recovered from femurs of age-matched mice from each genotype. Mean values ± SD 
obtained from the indicated number of mice (n) are given. WBC, white blood cell count; RBC, red blood cell count; MCV, mean cell volume; MCH, mean corpuscular 
hemoglobin; MCHC, mean corpuscular hemoglobin concentration.JEM VOL. 206, May 11, 2009 
ARTICLE
1185
Figure 2.  Analysis of bone marrow neutrophils in ARKO mice. (A) FSC/SSC analysis of bone marrow cells shows reduction of a cell population with 
granulocyte characteristics in 8-wk-old ARKO mice (n = 4) compared with WT littermates (n = 4). (B) Gated with CD45+, FACS analyses show that bone 
marrow neutrophils are significantly decreased in AR-deficient mice (n = 4) compared with WT littermates (n = 4). (C) FACS analysis with antibodies 
against neutrophils in peripheral blood from 10-wk-old sham-operated WT, castrated (WT-Cas), castrated mice implanted with DHT-releasing pellet (WT-
Cas+DHT), sham-operated ARKO (ARKO), and sham-operated ARKO mice implanted with DHT-releasing pellet (ARKO+DHT). For each group, 105 cells from 
each of four mice were pooled and analyzed. Data were analyzed using CellQuest software; neutrophil populations are shown as histograms. DHT supple-
mentation restores neutrophil numbers in peripheral blood of castrated mice, but not in ARKO mice. (D) DHT supplementation restores bone marrow neu-
trophils (neutrophil-specific antibody, clone 7/4, labeled) in castrated mice, but not in ARKO mice. (E) DHT supplementation also restores neutrophils (Gr-1 
labeled) in bone marrow of castrated mice, but not in those of Tfm mice. (F) Neutrophil differential counts are only moderately reduced in patients after 
androgen ablation therapy. Blood analysis data were collected from 33 advanced prostate cancer patients before and after surgical castration. Neutrophil 
differential counts are shown and presented as the mean ± SD. Animal experiments were independently performed at least three times, and representa-
tive results from one experiment are shown.1186 NEUTROPENIA IN AR-DEFICIENT MICE | Chuang et al.
Figure 3.  AR knockdown in WT myeloid progenitors by RNA interference (RNAi) suppresses neutrophil differentiation, and restoring AR in 
ARKO cells induces neutrophil differentiation. (A) Bone marrow cells were plated in methylcellulose-containing media supplemented with the indicated 
cytokine and hematopoietic colonies containing >30 cells were scored after 7 d. We analyzed bone marrow cells from five 9-wk-old animals of each geno-
type. (B) Effect of adding various concentrations of DHT on colony formation of mouse bone marrow cells in methylcellulose-containing media supple-
mented with G-CSF. (C) The populations of GMPs and CMPs are comparable in bone marrow between WT and ARKO mice. GMPs were further isolated from 
WT and ARKO bone marrow using FACS sorting. (D) Representative photomicrographs of isolated neutrophils and precursors from bone marrow stained 
with Wright-Giemsa. A decrease of nuclei-segmented neutrophils (arrow heads) in ARKO bone marrow is observed when compared with the control. Bar, 
10 µm. (E) GMPs were infected with retroviruses carrying pBabe vector, pBabe-AR, pSuperior vector, pSuperior-siAR, and pSuperior-scramble. Transduced 
GMPs were cultured in the presence of G-CSF (10 ng/ml) with or without 10 nM DHT for 7 d. Green fluorescent colony cells were then collected and JEM VOL. 206, May 11, 2009 
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AR-small interfering (si)RNA to see if knockdown of endoge-
nous AR retards neutrophil differentiation. We confirmed the 
AR-siRNA knockdown efficiency with reporter assays (Fig. S1) 
and immunoblot analyses of AR protein expression in cells in-
fected  with  retroviruses  carrying  AR-siRNA  and  scramble 
siRNA control (Fig. S2). Colonies from sorted WT GMPs in-
fected with retroviruses carrying AR-siRNA and GFP showed 
fewer mature neutrophils than those infected with retroviruses 
carrying scrambled siRNA and GFP or GFP alone (Fig. 3 E). 
These results are consistent with the ARKO mouse data, sug-
gesting that knockdown of endogenous AR by siRNA in GMPs 
could retard neutrophil maturation. Results from these comple-
mentary methods of AR manipulation in cultured cells are con-
sistent with our in vivo ARKO mice data showing that loss of 
AR results in retardation of neutrophil differentiation.
Reduced proliferative activity in neutrophil precursors  
in bone marrow of ARKO mice
We next examined granulocytic proliferation via analysis of 
the cell cycling status of granulocytes within bone marrow, 
by labeling cells with anti–Gr-1 antibodies and propidium 
iodide. The proportion of cells in S and G2/M phase was lower 
in Gr-1+ bone marrow cells from ARKO mice (Fig. 4 A), sug-
gesting that the rate of granulocytic proliferation in bone 
marrow from ARKO mice is lower than in WT mice.
To learn more about the dynamics of neutrophil production 
in WT and ARKO mice, we labeled mitotic progenitors/pre-
cursors in vivo by intraperitoneal injection of BrdU, which only 
labels proliferating cells. Cells derived from the neutrophil pre-
cursor pool can be labeled with BrdU because these cells are 
proliferating and have matured into granulocytes, which are 
then released from the bone marrow into the circulation. At   
96 h after the injection, the BrdU-labeled granulocytes reached 
a maximum in the peripheral blood (Fig. 4 B). It is known that 
BrdU labeling intensity is diluted by half with every cell division 
after BrdU incorporation. Consequently, by tracking the changes 
in relative BrdU intensity, we can determine how many division 
cycles the neutrophils from precusor cells have undergone. Cells 
in the BrdUbright region correspond to granulocytes that incor-
porated BrdU in their last mitosis, whereas those in the BrdUdim 
region have gone through one or more divisions after BrdU in-
corporation. As shown in Fig. 4 C, 40% of neutrophils were in 
the BrdUdim pool in WT mice, whereas only 22% of neutrophils 
from ARKO mice were BrdUdim, suggesting a markedly re-
duced mitotic cell division of neutrophil precursors in bone 
marrow of ARKO mice.
Granulocytes from bone marrow of ARKO mice  
are susceptible to apoptosis
To determine if neutropenia in ARKO mice is partly caused 
by neutrophil apoptosis, we examined the bone marrow cell 
ARKO mice have a defect in granulopoiesis between 
proliferative precursors and mature neutrophils with normal 
numbers of myeloid progenitors
We next asked which stages during granulopoiesis in bone   
marrow are responsible for neutropenia in ARKO mice. Using 
colony-forming assays, we discovered that adding G-CSF, GM-
CSF, macrophage-colony stimulating factor (M-CSF), IL-3, 
and IL-6 induced similar levels of colony formation in ARKO 
bone marrow cells and WT cells in low-androgen methylcellu-
lose medium (Fig. 3 A). Adding DHT did not influence colony 
numbers induced by G-CSF (Fig. 3 B). These results suggest 
that the populations of early granulocytic and monocytic pro-
genitor cells are comparable in WT and ARKO bone marrow 
cells. Thus, we conclude that neutrophil lineage commitments 
in ARKO mice must be similar to those in WT mice. In addi-
tion, using FACS analyses, we found that the abundance of both 
common myeloid progenitors (CMPs) and granulocyte/macro-
phage progenitors (GMPs) in bone marrow is also comparable 
between WT and ARKO mice (Fig. 3 C). Using Wright-Gi-
emsa staining of bone marrow smears, we found that fewer iso-
lated bone marrow neutrophils from ARKO mice than from 
WT mice had segmented nuclei (Fig. 3 D). Differential count-
ing of bone marrow cells showed that ARKO mice had a de-
crease in myelocytes/metamyelocytes and a marked decrease in 
mature neutrophils as compared with bone marrow cells from 
WT mice (Table I C). Although we observed that cancellous 
bone volumes of ARKO male mice are reduced compared with 
WT littermates (12), there is no difference in bone marrow cel-
lularity (Table I C). These results suggest that the defect in gran-
ulopoiesis of ARKO mice occurs during the transition between 
proliferation of precursors (myeloblasts, promyelocytes, and my-
elocytes) and maturation of neutrophils (metamyelocytes, band 
forms, and neutrophils), leading to a defect in terminal differen-
tiation of neutrophils.
Restoration and knockdown of AR in GMPs influence 
neutrophil differentiation
To see if restoration of AR rescues neutrophil differentiation, 
we infected FACS-sorted ARKO GMPs with retroviruses car-
rying the cDNA for AR and GFP or retroviruses carrying GFP 
alone, and then seeded infected cells into methylcellulose me-
dium in the presence of G-CSF. Fluorescent colonies were har-
vested  after  7  d.  ARKO  colonies  infected  with  retroviruses 
carrying GFP alone exhibited fewer mature neutrophils   
(Fig. 3 E). In contrast, colonies from ARKO GMPs infected 
with retroviruses expressing functional AR consisted of more 
mature neutrophils, suggesting that the defects in neutrophil 
maturation resulting from ablation of AR can be rescued by AR 
overexpression. Again, we found that adding androgen did not 
result in an additional rescue on neutrophil maturation (Fig. 3 E). 
Also,  we  infected  WT  GMPs  with  retroviruses  carrying 
counted. 200-count manual leukocyte differentials were examined after Wright-Giemsa staining. Numbers of neutrophils and precursor cells were calcu-
lated by multiplying neutrophil differential ratios by the total green fluorescent cell count. Triplicate experiments were performed and the error bars repre-
sent the SD.
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apoptosis using a FACS-based assay with Annexin V and 
7-amino-actinomycin-D (AAD) staining. We did not observe a 
significant number of apoptotic Gr-1+ cells in fresh bone mar-
row from either WT or ARKO mice (Fig. 5 A), which might 
be caused by rapid clearing of apoptotic cells by macrophages in 
vivo. We then examined survival of mature bone marrow neu-
trophils in vitro and found that 25% of ARKO neutrophils were 
apoptotic cells as compared with 19% in WT cells in culture 
without G-CSF treatment, indicating that ARKO neutrophils 
are moderately more susceptible to spontaneous apoptosis than 
WT cells (Fig. 5 B). On the other hand, with G-CSF treatment 
for 48 h, only 10% of WT neutrophils, but 20% of ARKO 
neutrophils, remained apoptotic (Fig. 5 B). These results suggest 
that G-CSF is unable to delay apoptosis in ARKO neutrophils.
Together, the proliferation and apoptosis assays suggest 
that neutropenia resulting from loss of AR might be caused 
by decreased proliferation of neutrophil precursors and in-
creased apoptosis of neutrophils in bone marrow.
The response to G-CSF is impaired in granulocytes  
lacking AR
G-CSF–mediated apoptosis protection might be less effective 
in ARKO granulocytes because of impaired response to G-CSF. 
To  investigate  the  granulopoietic  response  to  G-CSF  in 
Figure 4.  Proliferative potential of neutrophil precursor and progenitor cells. (A) Cell cycle analysis of total bone marrow Gr-1+ cells from WT and 
ARKO mice. Comparison of cell cycle distributions shows that 9-wk-old ARKO mice have a lower percentage of cells in the S-phase and the G2/M phase 
of the cell cycle compared with WT littermates. Data are presented as the mean ± standard deviations (SD) of three independent experiments in the right 
panel. (B) Kinetics of BrdU labeled neutrophils in the blood of WT and ARKO mice after BrdU injection. (C) Comparison of BrdU incorporation in WT and 
ARKO blood neutrophils. At 96 h post injection, the ratio of BrdUdim in blood neutrophils is lower in 9-wk-old AR-deficient mice (n = 4) as compared with 
WT littermates (n = 4). For each group, 105 cells from each of four mice were pooled and used for analysis. The results are presented as percentage of 
blood neutrophils from four-replicate experiments and the error bars represent the SD in the right panel.JEM VOL. 206, May 11, 2009 
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to G-CSF signaling in AR-deficit myeloid cells. Using real-
time quantitative PCR (Q-PCR), we measured the mRNA 
expression  of G-CSF–downstream  target  genes,  such as 
SOCS3, flotillin, chemokine (C-C motif) receptor-like 2, 
glycerol kinase, and complement component 3a receptor 1, 
WT and ARKO littermates, we monitored blood neutrophil 
counts with daily injections of G-CSF for 9 d (Fig. 5 C). We 
observed that ARKO mice had lower increasing rate of blood 
neutrophils in response to G-CSF as compared with WT 
mice. These results suggest that there might be an inhibition 
Figure 5.  Insensitivity to G-CSF signaling in ARKO neutrophils. (A) Only few apoptotic neutrophils can be found in freshly isolated WT and ARKO 
bone marrow cells. (B) G-CSF protection against apoptosis in ARKO bone marrow neutrophils was less than in WT cells in vitro. Isolated mature bone mar-
row neutrophils were cultured in RPMI medium with 20% FCS without or with G-CSF (100 ng/ml) for 48 h. Neutrophils were then stained with Annexin  
V and 7-AAD, and analyzed by flow cytometry. (C) A lower increasing rate of blood neutrophils was found in ARKO mice in response to G-CSF injection.  
(D) G-CSF target genes are down-regulated in ARKO neutrophils. Data represent mean ± SD for three separate experiments. *, P < 0.05; **, P < 0.01.  
(E) SOCS3 protein expression is decreased in ARKO neutrophils. (F) mRNA expression of G-CSFR is comparable between WT and ARKO neutrophils.  
(G) G-CSF binding to WT and ARKO neutrophils is similar.1190 NEUTROPENIA IN AR-DEFICIENT MICE | Chuang et al.JEM VOL. 206, May 11, 2009 
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mice, which is more than that from WT mice (Fig. 6 D). 
This result suggests that loss of AR in ARKO granulocytes re-
sults in increased PIAS3-mediated sequestering of pY-Stat3, 
leading to the suppression of G-CSF signaling. A reporter assay 
further showed that suppression of constitutively active Stat3 
(CA-Stat3) transactivation by PIAS3 was relieved by AR in a 
dose-dependent manner (Fig. 6 E). Notably, the major induc-
tion of Stat3 reporter is through increasing AR and is only 
slightly enhanced by adding androgen (Fig. 6 E), suggesting 
that androgen is not required for the AR’s rescue of stat3 activ-
ity from the inhibition by PIAS3.
Stat3 activation has been demonstrated to promote dif-
ferentiation of myeloid cell lines (34, 35, 40–43). To further 
investigate if increased activated Stat3 can rescue differentia-
tion of ARKO myeloid progenitors, we infected primary bone 
marrow GMPs with retroviruses carrying CA-Stat3, dominant-
negative Stat3 (DN-Stat3), or retroviruses carrying pMSCV 
vector alone. We seeded infected cells into methylcellulose me-
dium in the presence of G-CSF, and harvested colonies after   
7 d. WT and ARKO colonies infected with retroviruses carry-
ing DN-Stat3 exhibited fewer mature neutrophils (Fig. 6 F). In 
contrast, WT and ARKO colonies infected with retroviruses 
expressing CA-Stat3 contained more mature neutrophils 
(Fig. 6 F). These results suggest that blocking endogenous 
Stat3 function by overexpression of DN-Stat3 could retard 
neutrophil differentiation, whereas increase of CA-Stat3 
could rescue neutrophil differentiation.
To further explore the relationship between AR and PIAS3 
in granulocytic differentiation, we examined differential counts 
of neutrophils in colonies infected with PIAS3 and PIAS3-
siRNA. We infected primary WT and ARKO GMPs with 
retroviruses carrying PIAS3, PIAS3-siRNA, and controls. We 
then seeded infected cells into methylcellulose medium with 
G-CSF for 7 d, and then examined differential counts of fluo-
rescent colony cells. We found PIAS3 overexpression reduced 
mature neutrophils, but increased AR could rescue the reduc-
tion (Fig. 6 G). We also found that PIAS3 knockdown by 
PIAS3-siRNA could restore mature neutrophil numbers in 
ARKO colonies (Fig. 6 H).
The binding of G-CSF to its receptor activates not only 
the Jak–Stat3 pathway (44) but also the Ras–Raf–ERK sig-
naling cascade (45). No ERK1/2 activation was found in WT 
and ARKO neutrophils before G-CSF treatment (Fig. 7 A). 
We observed that ERK1/2 phosphorylation was significantly 
decreased in ARKO bone marrow granulocytes with G-CSF 
and found their mRNA expressions were decreased in ARKO 
granulocytes (Fig. 5 D). Protein expression of SOCS3, a major 
downstream target of G-CSF, was also significantly reduced 
(Fig. 5 E) in isolated bone marrow granulocytes from ARKO 
mice compared with those from WT littermates. These results 
suggest that G-CSF signaling could be suppressed in ARKO 
granulocytes. We then examined the expression of G-CSFR 
using semiquantitative RT-PCR and a flow cytometric–based 
G-CSF binding assay. We saw no difference in mRNA and 
surface protein expression of G-CSFR between granulocytes 
from ARKO and WT mice (Fig. 5, F and G).
Stat3 activity and ERK activation in G-CSF signaling  
are reduced in ARKO granulocytes
To investigate if downstream mediators of G-CSF signaling 
are suppressed by AR deficiency, we examined the expression 
of Stat3, a proximal mediator of the G-CSF signaling (34, 35). 
We found that the expression of both total Stat3 and the tyro-
sine-phosphorylated form of Stat3 (pY-Stat3) were similar be-
tween isolated bone marrow neutrophils from WT and those 
from ARKO mice in the absence or presence of G-CSF stim-
ulation (Fig. 6 A). Similar levels of Stat3 and pY-Stat3 proteins 
were also observed in bone marrow neutrophils from castrated 
mice and those from WT and ARKO in the presence of 
G-CSF (Fig. 6 B). These results suggest that loss of AR does 
not influence the expression or the function of G-CSFR. Inter-
estingly, we found that endogenous AR of granulocytes from 
castrated mice is less abundant (Fig. 6 B), which could be 
caused by the decrease of AR protein stability in the prolonged 
absence of androgen (36, 37). This is further supported by the 
finding that castration resulted in a significant reduction of AR 
expression and that exogenous DHT administration restored 
the reduced AR expression (38).
Because early studies have demonstrated that PIAS3 could 
inhibit Stat3 signaling via blocking Stat3 DNA binding (39), 
we sought to explore if AR interacts with PIAS3 and affects its 
inhibition on Stat3 activity. The glutathione S-transferase 
(GST) pull-down data shows that there is a direct protein–pro-
tein interaction between PIAS3 and AR (Fig. 6 C). The PIAS3 
interaction with AR possibly occurs through the PIAS3 N ter-
minus, which contains a LXXLL motif, an -helical protein 
interaction module that mediates interactions between AR co-
regulators and AR. Using a coimmunoprecipitation assay, we 
found that anti-PIAS3 antibodies can precipitate more pY-Stat3 
in granulocytes from ARKO, followed by that from castrated 
Figure 6.  Stat3 transcriptional activity is reduced in ARKO neutrophils. (A) PIAS3, Stat3, and pY-Stat3 proteins are comparable in WT and ARKO 
bone marrow neutrophils. Cells were isolated from mice and then incubated with G-CSF (40 ng/ml) at 37°C for the indicated period. (B) AR protein ex-
pression is lower in bone marrow neutrophils of castrated mice than those of WT mice, while Stat3 and pY-Stat3 levels are comparable. Bone marrow  
Gr-1+ cells were isolated from mice and then incubated with G-CSF (40 ng/ml) at 37°C for 30 min. (C) AR interacts with the GST-PIAS3 in the GST pull-down 
assay. (D) Binding of Stat3 by PIAS3 is more in ARKO bone marrow neutrophils. The result of band intensities of Stat3, pY-Stat3, and AR in the coimmuno-
precipitation experiment was normalized with band intensities of PIAS3 and shown in the right panel. (E) AR can relieve the PIAS3 inhibition of acti-
vated Stat3 action. The results are presented as fold induction of luciferase activity from triplicate experiments using CV-1 cells and the error bars 
represent the SD. ***, P < 0.001. (F) CA-Stat3 induces but DN-Stat3 inhibits neutrophil maturation. (G) PIAS3 inhibits neutrophil maturation, while in-
creased AR rescues the inhibition. (H) PIAS3-siRNA increases neutrophil maturation. Results are presented as cell numbers of neutrophils and precursors 
from triplicate experiments and the error bars represent the SD. *, P < 0.05; **, P < 0.01; ***, P < 0.001.
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Figure 7.  AR is essential for ERK1/2 activation in G-CSF induced neutrophil proliferation. (A) With G-CSF (40 ng/ml) treatment for the indicated 
times, ERK1/2 phosphorylation status was examined in bone marrow neutrophils of WT, castrated WT, and ARKO mice. (B) AR is required for G-CSF-
induced ERK1/2 phosphorylation. By immunoblotting, the expression status of phosphorylated ERK1/2 and total ERK1/2 were compared among each group  
of G-CSF–induced granulocytes derived from WT or ARKO bone marrow cells infected with retroviruses carrying AR, AR-siRNA, or control vectors. v, vec-
tor alone; Sc, pSuperior-scrambled siRNA; Si-AR, pSuperior-AR siRNA. (C) U0126 almost abolishes G-CSF–induced proliferation of bone marrow cells. In 
the presence or absence of G-CSF (10 ng/ml), bone marrow cells (106/ml) were incubated with or without 1 µM U0126 for 3 d. Proliferative activity was 
then examined by 3H-thymidine incorporation. (D) Effects of AR deficiency on the human myeloblastic cell line, KG-1. Stably transfected cells were plated 
at 5 × 105 cells/ml in RPMI medium and the number of total viable cells was calculated each day. Results are the mean of three independent experiments 
and the error bars represent the SD. (E) Schematic representation of the role of AR in G-CSF signaling.JEM VOL. 206, May 11, 2009 
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ARKO neutrophils show reduced neutrophil migration  
in response to CXCR2 ligands, but exhibit normal  
neutrophil degranulation
The chemokine receptor CXCR2 plays an important role in 
neutrophil migration (46). Neutrophil chemoattractants macro-
phage-inflammatory protein-2 (MIP-2) and KC/CXCL1 can 
specifically bind to CXCR2, whereas fMLP signals through a 
different G protein–coupled receptor (47–50). To test the mi-
gration capability of ARKO neutrophils, we examined the che-
motactic response toward MIP-2, KC, and fMLP. As shown in 
Fig. 8 D, ARKO neutrophils demonstrated reduced migration 
activities toward the chemoattractants MIP-2 and KC compared 
with WT cells; however, ARKO and WT neutrophils had simi-
lar responses to fMLP. It has been shown that lack of Stat3 can 
impair CXCR2-dependent neutrophil migration (51), and our 
results are correlated with that finding because the Stat3 activity 
is mostly inhibited in ARKO neutrophils.
We then examined the release of -glucuronidase and 
lactoferrin as the markers of primary and secondary granules 
from isolated mature neutrophils after stimulation. We found 
that WT and ARKO neutrophils showed no differences in 
the  release  of  -glucuronidase  or  lactoferrin  induced  by 
fMLP, C5a, and PMA (Fig. 8 E).
ARKO mice are more susceptible to microbial infection
To explore if neutropenic ARKO mice have impaired host re-
sistance to acute bacterial infection, we injected 9-wk-old 
ARKO mice and age-matched WT controls (10 animals per 
group) intraperitoneally with a virulent strain of E. coli. Survival 
of the mice was monitored over 60 h. At 12 h after injection, 
all 10 ARKO mice showed signs of severe infection, including 
diarrhea, hunchback, imbalance, ruffled fur, and eye infection, 
but only 3 out of 10 WT mice exhibited signs of infection 
(Fig. 8 F). Moreover, all 10 ARKO mice were dead within   
36 h, and only 1 WT mouse died within that time frame   
(Fig. 8 G). All remaining WT mice were still alive at 60 h. The 
inability of the ARKO mice to survive the E. coli challenge 
shows that these animals are more susceptible than WT con-
trols to bacterial infection.
DISCUSSION
It is interesting that neutropenia was observed in ARKO and 
Tfm mice, whereas castrated male mice only have moderate 
reduction of neutrophil counts in both blood and bone mar-
row (Fig. 2, C–E), suggesting that AR, but not androgen, is 
critical for neutrophil homeostasis. Other evidences to support 
our hypothesis include the following: (a) Exogenous androgen 
can restore neutrophil counts in castrated WT mice, but not 
ARKO mice (Fig. 2, C–E). (2) Female ARKO mice have 
neutropenia, but WT female mice, with 10-fold less androgen 
levels compared with male, still maintain normal neutrophil 
counts (Fig. 1 H). (3) Our mechanistic studies indicate that AR 
reduces the inhibition of PIAS3 to Stat3 transcriptional activ-
ity, and adding androgen only mildly enhances the AR effect 
on Stat3 signaling (Fig. 6 E). (4) Without adding androgen, 
AR overexpression still increases granulocytic differentiation 
treatment (Fig. 7 A). We then found that in the presence of 
G-CSF, there is a decrease in phosphorylated ERK1/2 in 
WT bone marrow cells carrying AR-siRNA, whereas exog-
enous  AR  promotes  ERK1/2  activation  in  ARKO  bone 
marrow cells (Fig. 7 B). Next, we examined the effects of AR 
deficiency on the G-CSF–induced proliferation of primary 
bone marrow cells and the human myeloblastic cell line KG-1. 
Compared  with  ARKO  cells,  WT  bone  marrow  cells 
showed a significantly higher proliferative activity in response 
to G-CSF (Fig. 7 C). Similarly, under G-CSF treatment, WT 
KG-1 cells also showed higher cell proliferation than the 
KG-1 clone carrying hAR-siRNA (Fig. 7 D). Furthermore, 
we found that U0126 (MEK kinase inhibitor) abolished a 
large part of G-CSF-induced cell proliferation for those cells 
containing AR (Fig. 7 C and D). All of these results suggest 
that AR is essential for the G-CSF–induced ERK activa-
tion and subsequent granulocytic proliferation. It has been 
reported that AR is important for the activation of c-Src–
Ras–Raf–ERK signaling cascade through the interaction be-
tween the proline-rich motif of AR and the SH3 domain of 
c-Src (11). Also, our previous studies have demonstrated 
that AR contributes to ERK activation in an androgen-
independent manner (13).
Together, these results indicate that AR not only releases 
the PIAS3 inhibition of the Stat3 but also promotes ERK ac-
tivation in G-CSF signaling (Fig. 7 E).
Granulocytes from ARKO mice are capable of phagocytosis 
and oxidative burst, but have reduced chemokine  
and cytokine production
We then asked if any functions of neutrophils derived from 
ARKO mice were impaired as compared with WT controls. 
First, we examined the oxidative burst and phagocytic activi-
ties of granulocytes derived from ARKO and WT mice by in-
cubating granulocytes with fluorescein-labeled Escherichia coli 
at 37°C (Fig. 8 A). In addition, we assessed the oxidative burst 
in response to PMA, fMLP, or anaphylatoxin C5a stimulation 
by monitoring the production of H2O2, which converts 2,7-
dichlorofluorescein acetate, a nonfluorescent precursor, to 
2,7-dichlorofluorescein. The fluorescence intensity of 2,7-
dichlorofluorescein was comparable in the WT and ARKO 
neutrophils as stimulated by PMA (Fig. 8 B), fMLP (Fig. S3), 
or C5a (Fig. S3), showing that the oxidative burst capacity of 
the two genotypes was similar. These results suggest that both 
phagocytosis and the oxidative burst are normal in granulo-
cytes from ARKO mice.
Chemokines and cytokines are important for leukocyte 
migration and inflammatory response. To assess the expres-
sion of chemokines and proinflammatory cytokines in the 
current study, we used Q-PCR to measure the mRNA levels 
in WT and ARKO granulocytes. ARKO cells had lower lev-
els of IL-1, IL-6, TNF- mRNA, and several chemokines 
than WT cells (Fig. 8 C), suggesting that reduced production 
of chemokines and proinflammatory cytokines might influ-
ence the functions of neutrophils or other leukocytes through 
autocrine or paracrine pathways.1194 NEUTROPENIA IN AR-DEFICIENT MICE | Chuang et al.JEM VOL. 206, May 11, 2009 
ARTICLE
1195
Figure 8.  Neutrophil function and host defense against infection in the absence of AR. (A) Uptake of fluorescein-labeled E. coli by WT and ARKO 
neutrophils at 37°C. (B) Flow cytometric analysis of oxidant production and subsequent 2,7-dichlorofluorescein generation in WT and ARKO granulo-
cytes after PMA stimulation. (C) Relative mRNA expression of chemokines and cytokines in isolated WT and ARKO bone marrow granulocytes. *, P < 0.05. 
(D) Mature bone marrow neutrophils from WT or ARKO mice were tested for migration in Transwell chambers toward the indicated chemoattractant  
(200 ng/ml MIP-2, 1 µg/ml KC, or 100 µM fMLP). The number of cells migrated through the Transwell was determined by cell counting. Data from six indepen-
dent experiments are presented and the error bars represent the SD. *, P < 0.05; **, P < 0.01. (E) Neutrophil degranulation of WT and ARKO neutrophils 
was examined without or with stimulation by fMLP, C5a, or PMA. (top) The release of the primary granules was examined using the -glucuronidase ac-
tivity in the supernatant of stimulated neutrophils. Data are presented as the percentage of total cellular -glucuronidase content. (bottom) Release of 
the specific granule marker lactoferrin in the supernatant of stimulated neutrophils was quantified by ELISA. Both degranulation assays were performed 
in six independent experiments. (F) Representative photograph of WT and ARKO mice after 12-h intraperitoneal injection with E. coli. ARKO mice showed 
signs of severe infection, such as hunchback, ruffled fur, and eye infection; however, WT mice remained normal. (G) Kaplan-Meier survival curve of WT 
and ARKO mice in response to intraperitoneal challenge with E. coli. We examined the time course of survival following E. coli infection. Survival over time 
is shown as percentage mice remaining.
 
in colony formation assays (Fig. 3 E). With these observations, 
we believe that AR confers a direct and more profound effect 
than androgen. We note with interest that neutropenia result-
ing from AR ablation contrasts with the effect of knocking out 
the estrogen receptor . The estrogen receptor  KO mice 
show an overproduction of mature granulocytes (52). These 
opposing effects on granulopoiesis suggest that both AR and 
ER are required to maintain neutrophil homeostasis.
In vitro and transgenic mouse studies have demonstrated 
that Stat3 plays an essential role in G-CSF–dependent granu-
lopoiesis  (35,  51,  53–56).  Moreover,  several  reports  have 
shown that SOCS3 KO mice, in which Stat3 activity is per-
sistent, developed severe neutrophilia (57–59). Paradoxically, 
mice with targeted deletion of the Stat3 gene in hematopoi-
etic cells were also found to develop neutrophilia (60–63). 
Nevertheless, ERK1/2 hyperphosphorylation was found in 
bone marrow cells of Stat3 conditional KO mice, and it has 
been shown to contribute to neutrophilia in those animals 
(63). It is possible that the ERK1/2 hyperactivation results 
from SHP–Grb2–Src binding to available Stat3 docking sites 
on G-CSF receptor and overactivating the Ras–Raf–ERK 
signaling cascade. This possible signal crossover has been sug-
gested in some reports showing that G-CSFR truncated mu-
tants lacking the receptor C terminus, which contains tyrosine 
Y764 (the default docking site for SHP-2/Grb2), still have 
the ability to activate p21Ras via the SHP/Grb2 route linked 
to Y704 (the stat3 docking site) of the G-CSFR (41, 64). 
Clearly, further investigation is still required to determine the 
precise role of Stat3 in neutrophil development.
Several KO models have been established for genes in-
volved in the regulation of myelopoiesis. C/EBP/ mice 
have circulating myeloblast-like cells but lack mature neutro-
phils in vivo at birth. Although it was found that a lower 
PU.1:C/EBP ratio directs granulocytic differentiation over 
macrophage differentiation in myeloid cell fate determina-
tion, a PU.1/ mice study demonstrated that PU.1 is not 
essential for neutrophil lineage commitment, but is necessary 
for normal development, maturation, and function of neu-
trophils. Gfi/ mice are severely neutropenic and accumu-
late immature monocytic cells in blood and bone marrow. 
We found the mRNA levels of PU.1, C/EBP, and Gfi in 
ARKO bone marrow neutrophils are comparable to those 
detected in WT neutrophils (unpublished data), indicating 
that C/EBP, PU.1, and Gfi might not account for the gran-
ulopoietic defect observed in ARKO mice. Notably, a few   
mature neutrophils can still be observed in G-CSF/,   
G-CSFR/, and G-CSF/GM-CSF/M-CSF/ mice (5, 
65, 66), suggesting that a myeloid-CSF independent mecha-
nism exists in basal granulopoiesis. It might be interesting to 
further study whether AR also modulates a myeloid–CSF-
independent pathway.
Androgens can stimulate erythropoiesis and have been used 
clinically for treatment of aplastic anemia (26, 27). However, our 
data (Table I A) indicate that red blood cell numbers and hemo-
globin levels in WT and ARKO mice are similar, suggesting 
that AR is not required for steady-state erythrocyte production 
under physiological conditions. These results, however, are at 
odds with early reports showing that androgens could stimulate 
erythropoiesis (67). The diverse effect on erythropoiesis by dif-
ferent androgen derivatives is indicative of the complexity of an-
drogen control in erythropoiesis. 5-DHT binds to the AR and 
might stimulate erythropoiesis indirectly by increasing levels of 
erythropoietin, whereas 5 epimers (5-DHT and etiocholan-
olone) do not bind to the AR, yet effectively increase the 
number of erythropoietic progenitor cells, thereby also en-
hancing erythropoiesis (68–73). It will be interesting to study if 
androgen stimulates erythropoiesis through an AR-indepen-
dent pathway.
In summary, the data presented here indicate AR is es-
sential for steady-state granulopoiesis. Further studies that ex-
plore potential cross talk between AR and other myeloid 
regulators in granulopoiesis might help reveal a better under-
standing of how cell signaling networks tightly control neu-
trophil homeostasis.
MATERIALS AND METHODS
Mice.  Construction  of  targeting  vectors  and  generation  of  the  chimera 
founder mice have been previously described (12). The original strain back-
ground of the mosaic founder mice was C57BL6/129sv. We have generated 
floxed AR mice with a nearly pure C57BL/6 background by backcrossing 
the original C57BL6/129sv background floxed AR mice with pure C57BL/6 
background mice for more than eight generations. -Actin is constitutively 
and ubiquitously expressed; thus, the -actin promoter-driven Cre (ACTB-
Cre, FVB background; The Jackson Laboratory) will express and delete 
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creased neutrophil counts from smoking and infections were also prevented, 
and the results are statistically analyzed. We requested coded data from chart 
reviews that include only patient diagnosis, treatments, time of blood drawn, 
and blood analysis data.
FACS detection of BrdU-labeled neutrophils, cell cycle analysis, 
and  apoptosis  assays. The immunofluorescent staining of intracellular 
BrdU incorporation has been previously described (74). To study cycling 
status of granulocytes, we first stained bone marrow cells with FITC-Gr-1 
antibody, fixed cells in 70% ethanol and removed residual RNA by RNase 
A, and then further stained them with propidium iodide (final concentration 
5 µg/ml) for analysis by a FACSCalibur flow cytometer. Data were further 
analyzed using CellQuest Software (BD) for DNA histogram analysis of Gr-1+ 
cells. For neutrophil apoptosis assays, bone marrow cells were stained 
with Annexin-V and 7-AAD. High-SSC cell population was then gated for 
apoptosis analysis.
Hematopoietic progenitor cell assay. Single-cell suspensions of bone 
marrow (2.5 × 104 cells) in methylcellulose medium (MethoCult M3234, 
Stem Cell Technologies) were plated in 35-mm Petri dishes in triplicate and 
incubated at 37°C. Purified recombinant murine (rm)G-CSF (10 ng/ml), 
rmGM-CSF (10 ng/ml), rmM-CSF (10 ng/ml), rmIL-3 (10 ng/ml), and 
rmIL-6 (400 ng/ml) (R&D Systems) were used.
RNA analysis. Neutrophils were isolated by EasySep selection kit (Stem Cell 
Technologies) and total RNA was extracted from cells using TRIzol reagent 
(Invitrogen). We performed reverse transcription using Superscript II reverse 
transcription and oligo-dT primers (Invitrogen) on 250 ng of total RNA. In 
semiquantitative RT-PCR, cDNA was diluted 5, 25, 50, and 100 times, and 
an aliquot (2 µl) of the reverse transcription reaction was subjected to PCR in 
a thermocycler (MyCycler; BioRad Laboratories). -Actin was used as an in-
ternal control. Q-PCR was performed in a final volume of 25 µl containing   
1 µg cDNA, 12.5 µl SYBR Green Mix (2X), 6 pmol of each primer set. The 
primer sequences for Q-PCR are listed in Table S1. The reaction mixtures 
were incubated on a iCycler (BioRad Laboratories) real-time PCR amplifier 
(BioRad Laboratories) programmed at 50°C, 2 min; 95°C 10 min; then 40 
cycles for three steps at 95°C, 15 s to 60°C, 30 s to 72°C, 30 s; and finally at 
70°C for 10 min. HPRT mRNA was used as the internal control. Real-time 
Q-PCR was performed by determining the cycle at which the abundance of 
the accumulated PCR product crosses a specific threshold, the threshold cycle 
(CT) in each reaction. The difference in average CT values between the in-
ternal control and a specific gene was calculated for each individual and termed 
CT, which is comparable to the log-transformed, normalized mRNA abun-
dance. For each gene, at least three samples with triplicate amplifications were 
performed and mean ± SD taken for data analysis.
Construction. The retroviral vectors pBabe-AR and pBabe-PIAS3 were 
constructed by ligating digested PCR products of AR and PIAS3 cDNA into 
a pBabe vector containing the SV40 promoter-driven GFP. To generate vec-
tors for siRNA expression, the pSuperior-GFP-neo vector (OligoEngine) was 
digested and the annealed oligonucleotides were ligated into the vector. The 
nucleotide sequences for targeting mouse AR, PIAS3, and Stat3 were de-
signed as 5-TCTAGCCTCAATGAGCTTG-3, 5-GCCACTGCCCT-
TCTATGAA-3, and 5-AGCCGATCTAGGCAGATG-3, respectively. 
Scrambled control shRNA unrelated to AR, PIAS3, and Stat3 sequences were 
used as negative controls. hAR-siRNA was described previously (13).
Isolation of GMP precursor cells. The myeloid-committed precursor 
populations from murine bone marrow were isolated by first depleting lin-
eage marker–positive cells by means of immunomagnetic beads. The re-
maining cells were then stained with goat anti–rat immunoglobulin Texas 
red and anti–c-kit–APC and then enrichment sorted for Lin c-kit+ cells. 
The  enrichment-sorted  cells  were  then  stained  with  anti-FcRII/III 
(CD16/32)–FITC, anti–c-kit–APC, anti–IL-7R–Alexa Fluor 594, anti–
Sca-1–Alexa Fluor 594, and anti–CD34-biotin, followed by PE-avidin. The 
by PCR, as described previously (12). Male Tfm and WT control mice 
(C57BL/6J-A-Ta[6J]+/Y) were purchased from The Jackson Laboratory. All 
animal experiments were approved by the University Committee on Animal 
Resources of the University of Rochester.
Castration. Castration was performed under anesthesia using sterile instruments 
and gloves. A transverse scrotal incision was made, the testicles were exposed, the 
vas deferens and spermatic blood vessels were ligated, and the testicles were re-
moved. A sham operation was performed for noncastrated controls in which the 
testis and epididymis were only pulled out and then returned to the scrotum. 
The scrotal incision was closed using a single skin clip. Animals were placed in a 
clean cage and monitored until fully recovered from anesthesia.
Androgen supplementation. Androgen supplementation in castrated WT 
mice and ARKO littermates was achieved by subcutaneous implantation of 
60-d time-release pellets (Innovative Research of America) containing DHT 
(5 mg per pellet); mice were sacrificed 14 d after androgen supplementation. 
The levels of plasma DHT were determined by a DHT ELISA Kit (Alpha 
Diagnostic International) according to the manufacturer’s protocol.
Blood and bone marrow sampling. Between 6 a.m. and 8 a.m., we col-
lected peripheral blood through cardiac puncture using a heparinized 3-ml sy-
ringe with a 30-gauge needle on mice under anesthesia. We dissected the 
femur free from the muscle, and then cut both at the knee and hip for removal. 
We removed bone marrow from each femur by flushing with 1 ml RPMI 
1640 (using a 26-gauge needle and a 1-ml syringe) into a single well of a 6-well 
culture plate.
Cytology and automated hematology analysis. Bone marrow smears, 
blood smears, and cytospin preparations were stained with Wright-Giemsa 
for morphological assessment and manual differential counting. Hematologic 
parameters from blood samples obtained from 8–12-wk-old mice were mea-
sured using an Abbot CELL-DYN 4000 system.
Cell  isolation. We isolated neutrophils from bone marrow or peripheral 
blood by using the EasySep selection kit (StemCell Technologies) according to 
the manufacturer’s suggested procedures. Mature bone marrow neutrophils 
were isolated by discontinuous Percoll density gradient centrifugation.
Cell staining and FACS analysis. 1–5 × 105 cells were incubated on ice for 
30 min with saturating amounts of antibody. Cells were washed with ice-cold 
PBS containing 2% fetal bovine serum, and flow cytometric analyses were 
performed using a dual-laser FACSCalibur flow cytometer (BD). For analysis 
of white blood cell populations, we set gates to include those cells that were 
CD45+ and viable by FSC and SSC scan profiles. Neutrophils were stained by 
fluorochrome-conjugated, neutrophil-specific monoclonal antibodies (clone 
7/4; Invitrogen) or anti–Gr-1 antibodies (clone RB6-8C5; eBioscience). For 
intracellular AR staining, after cells were incubated with fixative buffer (2% 
paraformaldehyde) and permeabilized with permeabilization solution (0.1% 
saponin  in  PBS  containing  2%  fetal  bovine  serum),  intracellular  AR  was 
stained by anti-AR antibody (clone C-19; Santa Cruz Biotechnology, Inc.), 
followed by fluorochrome-conjugated anti–rabbit IgG antibodies. Data were 
collected and analyzed from at least 10,000 gated events using CellQuest soft-
ware (BD). To assess surface G-CSFR expression, G-CSF was biotinylated. 
Bone marrow Gr-1+ cells were incubated at 48°C for 1 h with biotinylated   
G-CSF (25 ng per 106 cells) in the presence or absence of a 100-fold molar ex-
cess of nonlabeled G-CSF, followed by incubation with FITC-conjugated 
streptavidin. All cells were analyzed on a FACSCalibur flow cytometer.
Neutrophil differential counts in humans before and after androgen 
ablation. We collaborated with the Department of Urology at the Sir Run 
Run Shaw Hospital to collect blood analysis data from each patient before 
and after surgical castration (0–2 wk before castration and 2–4 wk after castra-
tion). Appropriate data excluded any patients receiving radiation therapy 
and/or chemotherapy. Diurnal rhythms of neutrophil counts and possible in-JEM VOL. 206, May 11, 2009 
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[35S]methionine-labeled proteins (2 µl) generated with the TNT-coupled 
reticulocyte lysate system (Promega) were mixed with the glutathione–Sep-
harose-bound GST proteins at 4°C for 3 h to perform the pull-down assay. 
The bound proteins were separated on a 10% or 15% SDS-polyacrylamide 
gel and visualized by PhosphorImager (GE Healthcare).
In vitro proliferative activity. In the presence or absence of G-CSF   
(10 ng/ml), bone marrow mononuclear cells (106/ml) were incubated in RPMI 
with or without U0126 (20 µM). After 3 d, 0.5 µCi 3H-thymidine was added 
and the cells were cultured for an additional 8 h. Proliferative activity was then 
determined by 3H-thymidine incorporation.
Assessment of phagocytosis and oxidative burst assays. Heparinized 
blood was incubated with opsonized fluorescein-labeled E. coli (Invitrogen) 
either at 37°C or at 0°C (control) for 10 min. After erythrocyte lysis, cells were 
washed twice and then stained with CyChrome–anti-Gr-1 antibodies. Oxida-
tive burst in response to PMA was evaluated by detecting the intracellular con-
version of dichlorofluorescein diacetate (DCFH-DA) to 2,7-dichlorofluorescein 
by flow cytometry. Leukocytes were stained with CyChrome–anti-Gr-1 anti-
bodies and cells were mixed with 10 µM DCFH-DA and 10 nM PMA for 
5 min at 37°C. We examined intracellular 2,7 dichlorofluorescein content in 
WT and ARKO Gr-1+ cells. 10,000 gated Gr-1+ cells were analyzed using 
CellQuest software. We isolated fresh mature bone marrow neutrophils by 
discontinuous  Percoll  density  gradient  centrifugation  to  perform  oxidative 
burst assays in response to fMLP (1 µM) or C5a (1 µg/ml).
Neutrophil migration. Fresh WT and ARKO mature bone marrow neu-
trophils were obtained by discontinuous Percoll density gradient centrifuga-
tion. Neutrophils (5 × 105 cells) were then plated in 3 µm Transwells (Corning) 
with the indicated chemoattractant (200 ng/ml MIP-2, 1 µg/ml KC, or 
0.1 mM fMLP) in the lower chamber. The number of cells migrated through 
the Transwell was determined by cell counting after incubation for 2 h at 
37°C. Over 90% neutrophils remained viable at the end of the assay as judged 
by trypan blue exclusion.
Neutrophil degranulation. Cells (106/ml) were preincubated with 5 µg/ml 
cytochalasin B for 10 min and then stimulated with 1 µM fMLP, 0.5 µg/ml 
C5a, or 200 nM PMA for 20 min at 37°C. Reactions were stopped by cool-
ing on ice and cell suspensions were centrifuged. -Glucuronidase activity in 
supernatants of activated cells was measured spectrophotometrically using 
4-methylumbelliferyl--d-glucuronide  as  substrate  (75).  -Glucuronidase 
release is presented as the percentage of total cellular content. The secondary 
granule marker lactoferrin was determined by ELISA using anti-lactoferrin 
antibody (Sigma-Aldrich).
Survival after intraperitoneal infection. 10 WT and 10 ARKO mice 
were administered 5 × 105 colony forming units of E. coli (Serotype O18ac:
K1:H7; American Type Culture Collection) by intraperitoneal injection and 
were followed for survival over 60 h.
Statistical analysis. Data are presented as the mean ± SD from at least three 
experiments, and statistical analysis was performed by either two-tailed Stu-
dent’s t test or one-way analysis of variance. The statistical significance of dif-
ferences was set at P < 0.05.
Online supplemental material. Fig. S1 shows AR activity is knocked down by 
AR siRNA and restored by AR cDNA using retroviral infection in CV-1 cells. 
Fig. S2 shows AR-targeted disruption in colony cells derived from GMPs infected 
with retrovirus carrying AR-siRNA. Fig. S3 demonstrates that the oxidative 
burst induced by fMLP or C5a in WT and ARKO neutrophils was comparable. 
Table S1 shows primer sequences for Q-PCR analysis. Online supplemental ma-
terial is available at http://www.jem.org/cgi/content/full/jem.20082521/DC1.
The authors are grateful to Karen Wolf and Leroy Hanchett for manuscript 
preparation and thank Marshall Lichtman, James Palis, Stephen Welle, and 
GMP precursor population was sorted as Lin CD16/32+ CD34+ c-kit+ 
Sca-1 IL-7R cells.
Retroviral infection. Phoenix ectrophic cells were grown in DME supple-
mented with 10% FCS. Cells were typically seeded in 60-mm-diam plates at a 
density of 2.4 × 106 cells per plate and allowed to settle for 18 to 24 h. Cells were 
transfected with 5–10 µg of plasmid DNA using calcium phosphate transfection. 
The media containing the plasmid DNA precipitate were replaced with fresh 
media 16 h after transfection. Retroviral supernatants were collected 48 h after 
transfection from Phoenix cells transfected with the retroviral vector–based con-
structs and used to infect freshly sorted GMP precursor cells. Infections were 
performed with 1 ml of undiluted supernatant in 2 ml of DME plus 400 µg of 
Polybrene per ml at 37°C. After 4 h of incubation, 2 ml of DME with 10% FCS 
were added and incubated for an additional 20 h.
Green fluorescent colony formation and differentiation counting. 
After retroviral infection, single-cell suspensions of GMP precursor cells in 
methylcellulose medium (MethoCult M3234; StemCell Technologies Inc.) 
were plated in 35-mm culture dishes in triplicate and incubated at 37°C in the 
presence of rm G-CSF (10 ng/ml) in a humidified incubator maintained at 
5% CO2. After 7 d in culture, the numbers of green fluorescent colonies in 
each dish were counted, and green fluorescent colony cells were collected in 
suspension for cell counting. Cells were cytocentrifuged onto a microscope 
slide and stained with Wright-Giemsa for morphological assessment and 200-
count manual differential counting.
In vivo administration of G-CSF. We injected three pairs of WT and 
ARKO littermates subcutaneously with rmG-CSF at 40 ng/g mice from day 
0–8, and then examined blood neutrophil counts 4 h after G-CSF injection 
at the indicated days.
Reporter gene assays. CV-1 cells were transfected with 4 × IRF-LUC (1.5 µg) 
together with CA-Stat3 (0.5 µg), flag-PIAS3 expression construct (0.5 or 
1.0 µg), and increasing amounts of AR (0.5 or 1.0 µg) with plasmid amount 
balance. The media was changed 2 h after transfection, and cells were cultured 
in media containing 10% charcoal depleted-FBS for 24 h, followed by treat-
ment with or without 10 nM DHT for another 16–18 h. 5 ng phRL-TK per 
well was used as internal control. Cells were harvested, and the Luc activity 
was analyzed using Dual-Luc Reporter Assay System (Promega).
Immunoblot analysis of cells infected with retroviruses. We infected 
WT and ARKO GMPs or bone marrow cells with retroviruses carrying 
pBabe-AR, AR-siRNA, or controls. After retroviral infection, single-cell 
suspensions of bone marrow cells in methylcellulose medium were plated in 
culture dishes and incubated at 37°C in the presence of G-CSF (10 ng/ml). 
After 7 to 10 d in culture, colony cells were collected and further incubated 
with or without G-CSF (40 ng/ml) for 30 min, and cells were harvested for 
immunoblot analysis.
Immunoprecipitation. Cells were lysed in lysis buffer (50 mM Tris–HCl, 
pH 7.4, 0.3 M NaCl containing 1% NP-40, 1 mM sodium orthovanadate, 
1 mM phenylmethylsulfonyl fluoride, and 10 µg/ml each of aprotinin, pep-
statin, and leupeptin). Cell lysates were immunoprecipitated with anti-PIAS3 
antibody as indicated. The immunoprecipitates from cell lysates were re-
solved  on  5–20%  SDS–PAGE  and  transferred  to  Immobilon  membrane 
(Millipore). The membranes were then probed with each antibody as indi-
cated. Immunoreactive proteins were visualized using an enhanced chemilu-
minescence detection system (GE Healthcare) and analyzed using Quantity 
One software (BioRad Laboratories).
GST pull-down assay. GST-PIAS3 fusion protein and GST protein were 
obtained by transforming expressing plasmids into BL21 (DE3) pLysS strain-
competent cells followed with 1 mM isopropyl-D-thiogalactoside induc-
tion. GST fusion proteins were then purified by glutathione–Sepharose 4B 
as  instructed  by  the  manufacturer  (GE  Healthcare).  In  vitro  translated 1198 NEUTROPENIA IN AR-DEFICIENT MICE | Chuang et al.
  16.  Mantalaris, A., N. Panoskaltsis, Y. Sakai, P. Bourne, C. Chang, E.M. 
Messing, and J.H. Wu. 2001. Localization of androgen receptor expres-
sion in human bone marrow. J. Pathol. 193:361–366. 
  17.  Byron, J.W. 1970. Effect of steroids on the cycling of haemopoietic stem 
cells. Nature. 228:1204. 
  18.  Resegotti, L., C. Dolci, L. Bertero, A. Genovese, F. Podesta, and D. 
Testa. 1981. Treatment of aplastic anaemia with methenolone, stanozolol 
and nandrolone. A report of 130 cases. Panminerva Med. 23:243–248.
  19.  Udupa, K.B., and K.R. Reissmann. 1974. Acceleration of granulopoietic 
recovery by androgenic steroids in mice made neutropenic by cytotoxic 
drugs. Cancer Res. 34:2517–2520.
  20.  DiBenedetto, J. Jr., D.J. Higby, S.J. Chester, and M.M. Albala. 1980. 
Reversal of cyclophosphamide induced neutropenia by hypertransfusion 
and androgen therapy. J. Med. 11:385–392.
  21.  Horn, Y., and D.C. Price. 1972. The effect of androgens on erythroid 
and granulocytic marrow recovery in the irradiated rat. Acta Haematol. 
48:300–306. 
  22.  Horn, Y. 1971. The effect of androgenic hormones on bone marrow of 
rats receiving chemotherapy. Oncology. 25:512–519.
  23.  Horn, Y. 1972. A comparison of two androgenic hormones as leuko-
poietic agents in irradiated rats. Oncology. 26:16–24.
  24.  Horn, Y. 1971. Leucopoietic properties of four different androgenic 
hormones in irradiated rats. Scand. J. Haematol. 8:470–475.
  25.  D’Alessandro, N., N. Gebbia, F. Biondo, L. Campio, G. Leto, F. 
Tumminello, and L. Rausa. 1979. Haemopoietic effects of 7 alpha, 17 
beta dimethyltestosterone. Pharmacol. Res. Commun. 11:81–94. 
  26.  Sanchez-Medal, L., J. Pizzuto, E. Torre-Lopez, and R. Derbez. 1964. Effect 
of Oxymetholone in Refractory Anemia. Arch. Intern. Med. 113:721–729.
  27.  Sanchez-Medal, L. 1971. The hemopoietic action of androstanes. Prog. 
Hematol. 7:111–136.
  28.  Alter, B.P. 1992. Fanconi’s anemia. Current concepts. Am. J. Pediatr. 
Hematol. Oncol. 14:170–176. 
  29.  Freedman,  M.H.,  and  J.J.  Doyle.  1999.  Chapter  1:  Inherited  Bone 
Marrow Failure Syndromes. In Pediatric Hematology. Second edition. 
J. Lilleyman, I. Hann, and V. Blanchette, editors. p. 23–49.
  30.  Kennedy, B.J. 1965. Stimulation of hematopoiesis by androgenic hor-
mones. Geriatrics. 20:808–815.
  31.  Rawbone, R.G., and K.D. Bagshawe. 1972. Anabolic steroids and bone mar-
row toxicity during therapy with methotrexate. Br. J. Cancer. 26:395–401.
  32.  Ibanez, L., A.M. Jaramillo, A. Ferrer, and F. de Zegher. 2005. High 
neutrophil count in girls and women with hyperinsulinaemic hyperan-
drogenism: normalization with metformin and flutamide overcomes the 
aggravation by oral contraception. Hum. Reprod. 20:2457–2462. 
  33.  Gaspar, M.L., T. Meo, P. Bourgarel, J.L. Guenet, and M. Tosi. 1991. A 
single base deletion in the Tfm androgen receptor gene creates a short-
lived messenger RNA that directs internal translation initiation. Proc. 
Natl. Acad. Sci. USA. 88:8606–8610. 
  34.  de Koning, J.P., A.A. Soede-Bobok, A.C. Ward, A.M. Schelen, C. 
Antonissen,  D.  van  Leeuwen,  B.  Lowenberg,  and  I.P.  Touw.  2000. 
STAT3-mediated differentiation and survival and of myeloid cells in   
response to granulocyte colony-stimulating factor: role for the cyclin-de-
pendent kinase inhibitor p27(Kip1). Oncogene. 19:3290–3298. 
  35.  Shimozaki, K., K. Nakajima, T. Hirano, and S. Nagata. 1997. Involvement 
of STAT3 in the granulocyte colony-stimulating factor-induced differ-
entiation of myeloid cells. J. Biol. Chem. 272:25184–25189. 
  36.  Furutani, T., T. Watanabe, K. Tanimoto, T. Hashimoto, H. Koutoku, M. 
Kudoh, Y. Shimizu, S. Kato, and H. Shikama. 2002. Stabilization of an-
drogen receptor protein is induced by agonist, not by antagonists. Biochem. 
Biophys. Res. Commun. 294:779–784. 
  37.  Zhou, Z.X., M.V. Lane, J.A. Kemppainen, F.S. French, and E.M. 
Wilson. 1995. Specificity of ligand-dependent androgen receptor stabi-
lization: receptor domain interactions influence ligand dissociation and 
receptor stability. Mol. Endocrinol. 9:208–218. 
  38.  Antonio, J., J.D. Wilson, and F.W. George. 1999. Effects of castra-
tion and androgen treatment on androgen-receptor levels in rat skeletal 
muscles. J. Appl. Physiol. 87:2016–2019.
  39.  Chung, C.D., J. Liao, B. Liu, X. Rao, P. Jay, P. Berta, and K. Shuai. 
1997. Specific inhibition of Stat3 signal transduction by PIAS3. Science. 
278:1803–1805. 
Alexandra Livingstone for critical review. We thank Ke Shuai and Daniel Link for 
sharing PIAS3, 4 × IRF-Luc, pMSCV-Stat3C (CA-Stat3), and pMSCV-Stat3D (DN-
Stat3) plasmids. This work was supported by National Institutes of Health Grant 
DK073414 and the George Whipple Professorship Endorsement.
The authors have no conflicting financial interests.
Submitted: 6 November 2008
Accepted: 13 April 2009
REFERENCES
  1.  Demetri, G.D., and J.D. Griffin. 1991. Granulocyte colony-stimulating 
factor and its receptor. Blood. 78:2791–2808.
  2.  Souza, L.M., T.C. Boone, J. Gabrilove, P.H. Lai, K.M. Zsebo, D.C. 
Murdock, V.R. Chazin, J. Bruszewski, H. Lu, K.K. Chen, et al. 1986. 
Recombinant human granulocyte colony-stimulating factor: effects on 
normal and leukemic myeloid cells. Science. 232:61–65. 
  3.  Rex, J.H., S.C. Bhalla, D.M. Cohen, J.P. Hester, S.E. Vartivarian, and 
E.J. Anaissie. 1995. Protection of human polymorphonuclear leukocyte 
function from the deleterious effects of isolation, irradiation, and storage by 
interferon-gamma and granulocyte-colony-stimulating factor. Transfusion. 
35:605–611. 
  4.  Lord, B.I., M.H. Bronchud, S. Owens, J. Chang, A. Howell, L. Souza, and 
T.M. Dexter. 1989. The kinetics of human granulopoiesis following treat-
ment with granulocyte colony-stimulating factor in vivo. Proc. Natl. Acad. 
Sci. USA. 86:9499–9503. 
  5.  Lieschke, G.J., D. Grail, G. Hodgson, D. Metcalf, E. Stanley, C. Cheers, 
K.J. Fowler, S. Basu, Y.F. Zhan, and A.R. Dunn. 1994. Mice lacking 
granulocyte colony-stimulating factor have chronic neutropenia, granulo-
cyte and macrophage progenitor cell deficiency, and impaired neutrophil 
mobilization. Blood. 84:1737–1746.
  6.  Nazareth, L.V., and N.L. Weigel. 1996. Activation of the human andro-
gen receptor through a protein kinase A signaling pathway. J. Biol. Chem. 
271:19900–19907. 
  7.  Culig, Z., A. Hobisch, M.V. Cronauer, C. Radmayr, J. Trapman, A. 
Hittmair, G. Bartsch, and H. Klocker. 1994. Androgen receptor activation 
in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte 
growth factor, and epidermal growth factor. Cancer Res. 54:5474–5478.
  8.  Yeh, S., H.K. Lin, H.Y. Kang, T.H. Thin, M.F. Lin, and C. Chang. 1999. 
From HER2/Neu signal cascade to androgen receptor and its coactivators: 
a novel pathway by induction of androgen target genes through MAP 
kinase in prostate cancer cells. Proc. Natl. Acad. Sci. USA. 96:5458–5463. 
  9.  Xie, Y., D.W. Wolff, M.F. Lin, and Y. Tu. 2007. Vasoactive intesti-
nal peptide transactivates the androgen receptor through a protein kinase   
A-dependent  extracellular  signal-regulated  kinase  pathway  in  prostate 
cancer LNCaP cells. Mol. Pharmacol. 72:73–85. 
  10.  Kasbohm, E.A., R. Guo, C.W. Yowell, G. Bagchi, P. Kelly, P. Arora, 
P.J. Casey, and Y. Daaka. 2005. Androgen receptor activation by G(s) 
signaling in prostate cancer cells. J. Biol. Chem. 280:11583–11589. 
  11.  Migliaccio, A., G. Castoria, M. Di Domenico, A. de Falco, A. Bilancio, M. 
Lombardi, M.V. Barone, D. Ametrano, M.S. Zannini, C. Abbondanza, and 
F. Auricchio. 2000. Steroid-induced androgen receptor-oestradiol recep-
tor beta-Src complex triggers prostate cancer cell proliferation. EMBO J. 
19:5406–5417. 
  12.  Yeh, S., M.Y. Tsai, Q. Xu, X.M. Mu, H. Lardy, K.E. Huang, H. Lin, S.D. 
Yeh, S. Altuwaijri, X. Zhou, et al. 2002. Generation and characterization 
of androgen receptor knockout (ARKO) mice: an in vivo model for the 
study of androgen functions in selective tissues. Proc. Natl. Acad. Sci. USA. 
99:13498–13503. 
  13.  Yeh, S., Y.C. Hu, P.H. Wang, C. Xie, Q. Xu, M.Y. Tsai, Z. Dong, R.S. 
Wang, T.H. Lee, and C. Chang. 2003. Abnormal mammary gland devel-
opment and growth retardation in female mice and MCF7 breast cancer 
cells lacking androgen receptor. J. Exp. Med. 198:1899–1908. 
  14.  Hu, Y.C., P.H. Wang, S. Yeh, R.S. Wang, C. Xie, Q. Xu, X. Zhou, 
H.T. Chao, M.Y. Tsai, and C. Chang. 2004. Subfertility and defective 
folliculogenesis in female mice lacking androgen receptor. Proc. Natl. Acad. 
Sci. USA. 101:11209–11214. 
  15.  Matsumoto, T., H. Shiina, H. Kawano, T. Sato, and S. Kato. 2008. 
Androgen receptor functions in male and female physiology. J. Steroid 
Biochem. Mol. Biol. 109:236–241. JEM VOL. 206, May 11, 2009 
ARTICLE
1199
results in neutrophil expansion and induces a distinct, antiapoptotic and 
pro-oncogenic gene expression pattern. J. Leukoc. Biol. 82:975–985. 
  57.  Croker, B.A., D. Metcalf, L. Robb, W. Wei, S. Mifsud, L. DiRago, 
L.A.  Cluse,  K.D.  Sutherland,  L.  Hartley,  E.  Williams,  et  al.  2004. 
SOCS3 is a critical physiological negative regulator of G-CSF signaling 
and emergency granulopoiesis. Immunity. 20:153–165. 
  58.  Kimura, A., I. Kinjyo, Y. Matsumura, H. Mori, R. Mashima, M. Harada, 
K.R. Chien, H. Yasukawa, and A. Yoshimura. 2004. SOCS3 is a physi-
ological negative regulator for granulopoiesis and granulocyte colony-
stimulating factor receptor signaling. J. Biol. Chem. 279:6905–6910. 
  59.  Jenkins, B.J., A.W. Roberts, M. Najdovska, D. Grail, and M. Ernst. 
2005. The threshold of gp130-dependent STAT3 signaling is critical for 
normal regulation of hematopoiesis. Blood. 105:3512–3520. 
  60.  Takeda, K., B.E. Clausen, T. Kaisho, T. Tsujimura, N. Terada, I. Forster, 
and S. Akira. 1999. Enhanced Th1 activity and development of chronic 
enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. 
Immunity. 10:39–49. 
  61.  Lee, C.K., R. Raz, R. Gimeno, R. Gertner, B. Wistinghausen, K. 
Takeshita, R.A. DePinho, and D.E. Levy. 2002. STAT3 is a negative 
regulator of granulopoiesis but is not required for G-CSF-dependent 
differentiation. Immunity. 17:63–72. 
  62.  Welte, T., S.S. Zhang, T. Wang, Z. Zhang, D.G. Hesslein, Z. Yin, A. 
Kano, Y. Iwamoto, E. Li, J.E. Craft, et al. 2003. STAT3 deletion dur-
ing hematopoiesis causes Crohn’s disease-like pathogenesis and lethality: 
a critical role of STAT3 in innate immunity. Proc. Natl. Acad. Sci. USA. 
100:1879–1884. 
  63.  Kamezaki, K., K. Shimoda, A. Numata, T. Haro, H. Kakumitsu, M. 
Yoshie, M. Yamamoto, K. Takeda, T. Matsuda, S. Akira, et al. 2005. 
Roles of Stat3 and ERK in G-CSF signaling. Stem Cells. 23:252–263. 
  64.  de Koning, J.P., A.A. Soede-Bobok, A.M. Schelen, L. Smith, D. van 
Leeuwen, V. Santini, B.M. Burgering, J.L. Bos, B. Lowenberg, and I.P. 
Touw. 1998. Proliferation signaling and activation of Shc, p21Ras, and 
Myc via tyrosine 764 of human granulocyte colony-stimulating factor re-
ceptor. Blood. 91:1924–1933.
  65.  Liu, F., H.Y. Wu, R. Wesselschmidt, T. Kornaga, and D.C. Link. 1996. 
Impaired production and increased apoptosis of neutrophils in granulocyte 
colony-stimulating factor receptor-deficient mice. Immunity. 5:491–501. 
  66.  Hibbs, M.L., C. Quilici, N. Kountouri, J.F. Seymour, J.E. Armes, A.W. 
Burgess, and A.R. Dunn. 2007. Mice lacking three myeloid colony-stimu-
lating factors (G-CSF, GM-CSF, and M-CSF) still produce macrophages 
and granulocytes and mount an inflammatory response in a sterile model of 
peritonitis. J. Immunol. 178:6435–6443.
  67.  Fried, W., and C. Morley. 1985. Effects of androgenic steroids on eryth-
ropoiesis. Steroids. 46:799–826. 
  68.  Gardner, F.H., and E.C. Besa. 1983. Physiologic mechanisms and the 
hematopoietic effects of the androstanes and their derivatives. Curr. Top. 
Hematol. 4:123–195.
  69.  Beckman, B., B. Maddux, A. Segaloff, and J.W. Fisher. 1981. Effects of 
testosterone and 5 beta-androstanes on in vitro erythroid colony formation 
in mouse bone marrow. Proc. Soc. Exp. Biol. Med. 167:51–54.
  70.  Besa, E.C., and L.P. Bullock. 1981. The role of the androgen receptor 
in erythropoiesis. Endocrinology. 109:1983–1989.
  71.  Mooradian, A.D., J.E. Morley, and S.G. Korenman. 1987. Biological 
actions of androgens. Endocr. Rev. 8:1–28. 
  72.  Claustres, M., and C. Sultan. 1988. Androgen and erythropoiesis: evi-
dence for an androgen receptor in erythroblasts from human bone mar-
row cultures. Horm. Res. 29:17–22. 
  73.  Besa, E.C. 1994. Hematologic effects of androgens revisited: an alternative 
therapy in various hematologic conditions. Semin. Hematol. 31:134–145.
  74.  Basu, S., G. Hodgson, M. Katz, and A.R. Dunn. 2002. Evaluation of role 
of G-CSF in the production, survival, and release of neutrophils from bone 
marrow into circulation. Blood. 100:854–861. 
  75.  Dewald, B., and M. Baggiolini. 1986. Methods for assessing exocytosis 
by neutrophil leukocytes. Methods Enzymol. 132:267–277. 
  40.  Minami,  M.,  M.  Inoue,  S.  Wei,  K.  Takeda,  M.  Matsumoto,  T. 
Kishimoto, and S. Akira. 1996. STAT3 activation is a critical step in 
gp130-mediated terminal differentiation and growth arrest of a myeloid 
cell line. Proc. Natl. Acad. Sci. USA. 93:3963–3966. 
  41.  Ward, A.C., L. Smith, J.P. de Koning, Y. van Aesch, and I.P. Touw. 
1999. Multiple signals mediate proliferation, differentiation, and survival 
from the granulocyte colony-stimulating factor receptor in myeloid 32D 
cells. J. Biol. Chem. 274:14956–14962. 
  42.  Wang,  L.,  M.O.  Arcasoy,  S.S.  Watowich,  and  B.G.  Forget.  2005. 
Cytokine signals through STAT3 promote expression of granulocyte sec-
ondary granule proteins in 32D cells. Exp. Hematol. 33:308–317. 
  43.  Numata, A., K. Shimoda, K. Kamezaki, T. Haro, H. Kakumitsu, K. Shide, 
K. Kato, T. Miyamoto, Y. Yamashita, Y. Oshima, et al. 2005. Signal trans-
ducers and activators of transcription 3 augments the transcriptional activity 
of CCAAT/enhancer-binding protein alpha in granulocyte colony-stimu-
lating factor signaling pathway. J. Biol. Chem. 280:12621–12629. 
  44.  Corey, S.J., A.L. Burkhardt, J.B. Bolen, R.L. Geahlen, L.S. Tkatch, and 
D.J. Tweardy. 1994. Granulocyte colony-stimulating factor receptor sig-
naling involves the formation of a three-component complex with Lyn and 
Syk protein-tyrosine kinases. Proc. Natl. Acad. Sci. USA. 91:4683–4687. 
  45.  Matsuda, T., and T. Hirano. 1994. Association of p72 tyrosine kinase 
with Stat factors and its activation by interleukin-3, interleukin-6, and 
granulocyte colony-stimulating factor. Blood. 83:3457–3461.
  46.  Del Rio, L., S. Bennouna, J. Salinas, and E.Y. Denkers. 2001. CXCR2 
deficiency confers impaired neutrophil recruitment and increased suscep-
tibility during Toxoplasma gondii infection. J. Immunol. 167:6503–6509.
  47. Boulay, F., M. Tardif, L. Brouchon, and P. Vignais. 1990. The human   
N-formylpeptide receptor. Characterization of two cDNA isolates and   
evidence for a new subfamily of G-protein-coupled receptors. Biochemistry. 
29:11123–11133. 
  48.  Bozic, C.R., N.P. Gerard, C. von Uexkull-Guldenband, L.F. Kolakowski 
Jr., M.J. Conklyn, R. Breslow, H.J. Showell, and C. Gerard. 1994. The 
murine interleukin 8 type B receptor homologue and its ligands. Expression 
and biological characterization. J. Biol. Chem. 269:29355–29358.
  49.  Lee, J., G. Cacalano, T. Camerato, K. Toy, M.W. Moore, and W.I. 
Wood. 1995. Chemokine binding and activities mediated by the mouse 
IL-8 receptor. J. Immunol. 155:2158–2164.
  50.  Gao, J.L., E.J. Lee, and P.M. Murphy. 1999. Impaired antibacterial host 
defense in mice lacking the N-formylpeptide receptor. J. Exp. Med. 
189:657–662. 
  51.  Panopoulos, A.D., L. Zhang, J.W. Snow, D.M. Jones, A.M. Smith, 
K.C. El Kasmi, F. Liu, M.A. Goldsmith, D.C. Link, P.J. Murray, and 
S.S. Watowich. 2006. STAT3 governs distinct pathways in emergency 
granulopoiesis and mature neutrophils. Blood. 108:3682–3690. 
  52.  Shim, G.J., L. Wang, S. Andersson, N. Nagy, L.L. Kis, Q. Zhang, S.   
Makela, M. Warner, and J.A. Gustafsson. 2003. Disruption of the estro-
gen receptor beta gene in mice causes myeloproliferative disease resem-
bling chronic myeloid leukemia with lymphoid blast crisis. Proc. Natl. 
Acad. Sci. USA. 100:6694–6699. 
  53.  McLemore,  M.L.,  S.  Grewal,  F.  Liu,  A.  Archambault,  J.  Poursine-
Laurent, J. Haug, and D.C. Link. 2001. STAT-3 activation is required 
for normal G-CSF-dependent proliferation and granulocytic differentia-
tion. Immunity. 14:193–204. 
  54.  Panopoulos, A.D., D. Bartos, L. Zhang, and S.S. Watowich. 2002. 
Control of myeloid-specific integrin alpha Mbeta 2 (CD11b/CD18) ex-
pression by cytokines is regulated by Stat3-dependent activation of PU.1. 
J. Biol. Chem. 277:19001–19007. 
  55.  Hermans, M.H., C. Antonissen, A.C. Ward, A.E. Mayen, R.E. Ploemacher, 
and I.P. Touw. 1999. Sustained receptor activation and hyperproliferation 
in response to granulocyte colony-stimulating factor (G-CSF) in mice with 
a severe congenital neutropenia/acute myeloid leukemia-derived mutation 
in the G-CSF receptor gene. J. Exp. Med. 189:683–692. 
  56.  Redell, M.S., A. Tsimelzon, S.G. Hilsenbeck, and D.J. Tweardy. 2007. 
Conditional overexpression of Stat3alpha in differentiating myeloid cells 